WebBiochem./physiol. Wirkung. Phenprocoumon is a coumarin derivative that inhibits vitamin K and acts as a long acting oral anticoagulant. It was recently found to act synergistically with flutamide to modulate the stability of the androgen receptor (AR) and resensitize AR-mutant prostate cancer cells to flutamide. Web16. mar 2024 · Phenprocoumon (vor allem bekannt als Marcumar) ist ein Wirkstoff der zur Behandlung und Prophylaxe von Thrombosen und Embolien angewendet wird. Das …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in ...
Web26. máj 2024 · Results of the comparison of phenprocoumon and ld-DOACs regarding effectiveness and safety with Cox regression models showed consistency in analysis after PSM (Table 3). The outcome death was associated with the highest absolute risk increases with ld-DOAC subgroups compared to phenprocoumon ranging from 2.8% in the ld … WebPhenprocoumon (C 18 H 16 O 3, M r = 280.32 g/mol) ist ein Derivat von 4-Hydroxycumarin und ein Racemat. Das S - Enantiomer ist pharmakologisch aktiver. Phenprocoumon liegt als feines, weisses, kristallines Pulver vor, das in Wasser praktisch unlöslich ist. Wirkungen Phenprocoumon ( ATC B01AA04 ) hat gerinnungshemmende Eigenschaften. triplex broward cnty fl
Phenprocoumon acis® 3 mg 100 St - shop-apotheke.com
Web10. júl 2024 · We extracted INR and VKA dosing records of adult patients who used acenocoumarol or switched from acenocoumarol to phenprocoumon, in target ranges 2–3, 2.5–3.5 or 2–3.5 (used for low-intensity anticoagulation before switching to the internationally recommended target range of 2–3 on January 1st, 2016), indicated for … Web香豆素类( 醋硝香豆醇 ( 英语 : Acenocoumarol ) 、杀鼠迷、双香豆素、二羟香豆素乙酸乙酯、 苯丙羟基香豆素 ( 英语 : Phenprocoumon ) 、华法林) . 1,3-茚满二酮( 氯茚二酮 ( 英语 : Clorindione ) 、 二苯茚酮 ( 英语 : Diphenadione ) 、 苯茚二酮 ( 英语 : Phenindione ) ) . 其他( 噻氯香豆素 ... Web28. jan 2024 · As a subgroup within the IDrug study, phenprocoumon treated patients with at least two INR values within three months before enrollment (n = 209) were analyzed concerning average weekly dose, ... *2 and *3 carriers (p < .0001) and 16.0 ± 4.2 mg, 13.3 ± 5.1 mg and 8.0 ± 2.7 mg per week in VKORC1 CC, CT and TT genotypes, respectively (p < … triplex hornbach